Build engaged audiences through publishing by curation.
Sign up with Facebook
Sign up with Twitter
I don't have a Facebook or a Twitter account
Start a free trial of Scoop.it Business
According a new Federal Trade Commission (FTC) staff report, in Fiscal Year (FY) 2012, the number of "potentially anticompetitive patent dispute settlements" (aka, "Pay for Delay" deals) between branded and generic drug companies increased...
Are you sure you want to delete this scoop?